Literature DB >> 1092279

Management of acute aortic dissection.

F B Parker, J F Neville, E L Hanson, S Mohiuddin, W R Webb.   

Abstract

The therapy for acute dissecting aneurysm of the aorta remains a difficult problem for thoracic surgeons. Because of an excessive operative mortality in patients with acute dissection who were operated on within 24 hours of hospital admission, we have utilized intensive medical management to delay surgical intervention. Even patients with acute aortic insufficiency can be supported medically, allowing their operations to be delayed at least 3 weeks or longer. Since this policy has been implemented, there has been no operative mortality in our last 13 patients with acute dissection. Medical therapy as the definitive treatment is now reserved solely for Type III dissections or for patients who cannot be operated on for other reasons. This report outlines our rationale for therapy and our current method of managing acute dissection.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092279     DOI: 10.1016/s0003-4975(10)64045-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Total aortic repair: the new paradigm in the treatment of acute type A aortic dissection.

Authors:  George Matalanis; Nisal K Perera; Sean D Galvin
Journal:  Ann Cardiothorac Surg       Date:  2016-05

2.  Current status of medical therapy of acute dissecting aneurysms of the aorta.

Authors:  M W Wheat
Journal:  World J Surg       Date:  1980-09       Impact factor: 3.352

3.  Surgical treatment of aneurysms of the ascending aorta associated with severe aortic regurgitation.

Authors:  M J Antunes; A L Baptista; P R Colsen; R H Kinsley
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

4.  A machine learning model to classify aortic dissection patients in the early diagnosis phase.

Authors:  Da Huo; Bo Kou; Zhili Zhou; Ming Lv
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.